December 23, 2025 · Form 4 insider transaction
OBRIEN JAMES MICHAEL bought 650,000 shares of Mesoblast Limited at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 198 days after the transaction.
The exercise price for options is in Australian dollars.; Granted on December 23, 2025. Vesting is dependent on Mr. O'Brien achieving certain milestones